- Home
- ADVM vs HNVR Comparison
ADVM vs HNVR Comparison
Compare ADVM & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- HNVR
- Stock Information
- Founded
- ADVM 2006
- HNVR 2008
- Country
- ADVM United States
- HNVR United States
- Employees
- ADVM N/A
- HNVR N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- HNVR Commercial Banks
- Sector
- ADVM Health Care
- HNVR Finance
- Exchange
- ADVM Nasdaq
- HNVR Nasdaq
- Market Cap
- ADVM 119.6M
- HNVR 129.7M
- IPO Year
- ADVM 2014
- HNVR 2022
- Fundamental
- Price
- ADVM $6.04
- HNVR $23.94
- Analyst Decision
- ADVM Strong Buy
- HNVR Buy
- Analyst Count
- ADVM 6
- HNVR 1
- Target Price
- ADVM $27.83
- HNVR $22.00
- AVG Volume (30 Days)
- ADVM 252.6K
- HNVR 15.8K
- Earning Date
- ADVM 11-04-2024
- HNVR 10-23-2024
- Dividend Yield
- ADVM N/A
- HNVR 1.67%
- EPS Growth
- ADVM N/A
- HNVR N/A
- EPS
- ADVM N/A
- HNVR 1.84
- Revenue
- ADVM $1,000,000.00
- HNVR $64,015,000.00
- Revenue This Year
- ADVM N/A
- HNVR N/A
- Revenue Next Year
- ADVM $1,294.35
- HNVR $18.07
- P/E Ratio
- ADVM N/A
- HNVR $12.99
- Revenue Growth
- ADVM N/A
- HNVR 6.86
- 52 Week Low
- ADVM $5.69
- HNVR $13.62
- 52 Week High
- ADVM $29.70
- HNVR $25.80
- Technical
- Relative Strength Index (RSI)
- ADVM 31.12
- HNVR 81.66
- Support Level
- ADVM $6.81
- HNVR $20.57
- Resistance Level
- ADVM $7.73
- HNVR $25.80
- Average True Range (ATR)
- ADVM 0.46
- HNVR 1.24
- MACD
- ADVM -0.22
- HNVR 0.29
- Stochastic Oscillator
- ADVM 14.06
- HNVR 73.08
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.